Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1273
| Despition | BTB/POZ domain-containing protein 7 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1248 | Mitofusin 2 Blocking Peptide (AC1248) | 250 µg | inquiry |
| ACPP-1133 | Synthetic Nanodisc Human OR52D1 Protein (AC1133) | 10 µg | inquiry |
| ACPP-1058 | Recombinant Human TrkA Protein (Fc Tag) (AC1058) | 50 µg | inquiry |
| ACPP-1770 | Human AHSG Protein (AC1770) | 2 µg | inquiry |
| ACPP-1842 | Mouse TIMP1 (AC1842) | 2 µg | inquiry |
| ACPP-1776 | Human Acrp30 Protein, HMW (AC1776) | 2 µg | inquiry |
| ACPP-1099 | Synthetic Nanodisc Human Adenosine Receptor A2a Protein (AC1099) | 10 µg | inquiry |
| ACPP-1401 | Rat Midkine Protein (AC1401) | 5 µg | inquiry |
| ACPP-1738 | Human PNOC Protein (AC1738) | 5 µg | inquiry |
| ACPP-1009 | Recombinant Human TYRO3 Protein (6×His Tag) (AC1009) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.